TORONTO, May 8, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX: TGOD) (OTCQX: TGODF) is pleased to announce the Company's strategic investment into the US beverage space as... read more →
In an attempt to reduce the cannabis shortages throughout Canada, Health Canada announced today their plans to introduce changes to the way cannabis licenses are issued. Effective immediately, Health Canada will require... read more →
Company plans to add 203,000 square feet at three of its existing facilities located in Leamington, Ontario; London, Ontario; and Nanaimo, British Columbia NANAIMO, British Columbia--(BUSINESS WIRE)--Tilray Inc. (NASDAQ: TLRY),... read more →
VANCOUVER, British Columbia, May 08, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Transcanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to provide its shareholders and investors... read more →
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”)... read more →
More stars are making their love cannabis well known, as they have been launching their brands throughout the course of 2019. On Tuesday, April 30th, the Hall of Flowers, an... read more →
Ignite to capitalize on new UK and European markets with its super premium line of CBD products VAUGHAN, ON, May 7, 2019 /CNW/ - Ignite International Brands, Ltd. (CSE: BILZ) (the... read more →
Twelve SKUs Addressing Demand in Fast-Growing Animal Health CBD Sector BOULDER, CO, May 7, 2019 /CNW/ - (CSE: CWEB, OTCQX: CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web", or the "Company") the market share... read more →
SMITHS FALLS, ON, May 7, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) is pleased to introduce Spectrum Therapeutics, a new global brand that will encompass all... read more →
- Epidiolex U.S. Q1 net sales of $33.5m - - Positive Phase 3 pivotal results in Tuberous Sclerosis Complex, sNDA submission expected in Q4 2019 - - Conference call today... read more →
